Home › NDC Lookup › Ingredients › Gabapentin
📦 NDC / package directory — not a drug information page

Gabapentin NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Gabapentin products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Looking for uses, warnings & side effects? Read our Gabapentin drug information page →

Key stats

2,067
Package NDCs
783
Products
773
Active listings
10
Discontinued
126
Labelers
18
Strengths
9
Dosage forms
292
With NADAC pricing

By strength, form & labeler

NDC products by strength
GABAPENTIN 300 mg/1 184
GABAPENTIN 100 mg/1 165
GABAPENTIN 400 mg/1 129
GABAPENTIN 600 mg/1 121
GABAPENTIN 800 mg/1 104
GABAPENTIN 1 kg/kg 25
GABAPENTIN 250 mg/5mL 21
GABAPENTIN 1 g/g 8
GABAPENTIN 750 mg/1 4
GABAPENTIN 450 mg/1 4
By dosage form
CAPSULE 472
TABLET 131
TABLET, FILM COATED 90
POWDER 39
TABLET, COATED 25
SOLUTION 21
CRYSTAL 2
SUSPENSION 2
Top labelers
Bryant Ranch Prepack 100
REMEDYREPACK INC. 54
Proficient Rx LP 42
Aphena Pharma Solutions - Tennesse... 28
A-S Medication Solutions 24
ST. MARY'S MEDICAL PARK PHARMACY 24
Cardinal Health 107, LLC 21
Asclemed USA, Inc. 17

Browse records — 783 products

Drug / product Billing NDC NADAC / unit Status
RELGAABI Gabapentin 400 mg/1 CAPSULE Method · NDC 58657-0234-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (58657-234-01) 58657-0234-01 $0.042 /unit · NADAC On market View →
RELGAABI Gabapentin 300 mg/1 CAPSULE Method · NDC 58657-0233-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (58657-233-01) 58657-0233-01 $0.031 /unit · NADAC On market View →
RELGAABI Gabapentin 200 mg/1 CAPSULE Method · NDC 58657-0231-01 · 100 CAPSULE in 1 BOTTLE, PLASTIC (58657-231-01) 58657-0231-01 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.